SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
SEC Accession No. 0001104659-23-010008
Filing Date
2023-02-02
Accepted
2023-02-02 17:30:09
Documents
8
Effectiveness Date
2023-02-02

Document Format Files

Seq Description Document Type Size
1 FORM S-1MEF tm225197d18_s1mef.htm S-1MEF 36265
2 EXHIBIT 5.1 tm225197d18_ex5-1.htm EX-5.1 16877
3 EXHIBIT 5.2 tm225197d18_ex5-2.htm EX-5.2 25080
4 EXHIBIT 23.1 tm225197d18_ex23-1.htm EX-23.1 2003
5 EX-FILING FEES tm225197d18_ex-filingfees.htm EX-FILING FEES 11366
6 GRAPHIC tm225197d18_ex5-1img001.jpg GRAPHIC 23100
7 GRAPHIC tm225197d18_ex5-1img002.jpg GRAPHIC 21874
8 GRAPHIC tm225197d18_ex5-2img001.jpg GRAPHIC 15492
  Complete submission text file 0001104659-23-010008.txt   176503
Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Filer) CIK: 0001888886 (see all company filings)

IRS No.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-1MEF | Act: 33 | File No.: 333-269542 | Film No.: 23582439
SIC: 2834 Pharmaceutical Preparations